Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report

Systemic Capillary Leak Syndrome (SCLS) and Cytokine Release Syndrome (CRS) have both been described as rare but severe adverse reactions induced by Programmed cell death protein 1 (PD-1) inhibitors such as pembrolizumab. We report the case of a 40-year-old woman undergoing treatment with pembrolizu...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Eugénie Roberge-Maltais, Eric Lévesque, Vincent Castonguay, Nicolas Marcoux, Louis-Philippe Grenier, Martin Veilleux
Format:	Artigo
Język:	Inglês
Wydane:	MDPI AG 2025-08-01
Seria:	Current Oncology
Hasła przedmiotowe:	capillary leak syndrome cytokine release syndrome immune checkpoint inhibitors PD-1 inhibitors ruxolitinib axitinib
Dostęp online:	https://www.mdpi.com/1718-7729/32/8/469
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!